Hypercholesterolemia and related risk factors in a cohort of patients with diabetes and hypertension in Maputo, Mozambique.
Hypercholesterolemia
cardiovascular risk factor
non-communicable diseases
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
12
2020
accepted:
05
12
2020
entrez:
23
4
2021
pubmed:
24
4
2021
medline:
6
5
2021
Statut:
epublish
Résumé
some studies reported that 25.5% of African population presents hypercholesterolemia; however, epidemiology of hypercholesterolemia in Africa is poorly described. Mozambique is experiencing a constant growth of non-communicable diseases, but scarce data are available about hypercholesterolemia. Our study aims at describing the prevalence of hypercholesterolemia in patients with diabetes and hypertension in Mozambique and investigate possible risk factors. we conducted a cross-sectional study involving all the patients diagnosed with hypertension and/or diabetes from June 2018 to November 2020 in the Zimpeto DREAM Centre (Maputo, Mozambique). For each patient, anthropometric, clinical and laboratory data were collected. Hypercholesterolemia was defined as total blood cholesterol >200 mg/dL. Univariable and multivariable analysis were perfumed. a total of 885 patients were included, 76.2% (n=674) female. Hypertension alone was diagnosed in 670 (75.7%) patients, diabetes in 109 (12.3%) patients and 106 (11.9%) both diseases. Hypercholesterolemia was present in 410 (46.3%) patients and it was more prevalent in patients diagnosed with both diabetes and hypertension (52.8%), as compared to the patients diagnosed with hypertension (46.9%) or diabetes alone (36.7%). In the multivariable analysis, the only factors independently associated with hypercholesterolemia were female sex (aOR 1.77, 95% CI 1.26-2.48, p=0.001) and a body mass index >25kg/m our results highlight the need for a specific focus on female and obese/overweight patients, especially if diagnosed with both hypertension and diabetes, to promptly detect metabolic disorders and establish temporary preventive measures for cardiovascular events.
Identifiants
pubmed: 33889268
doi: 10.11604/pamj.2021.38.102.27284
pii: PAMJ-38-102
pmc: PMC8035689
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright: Fausto Ciccacci et al.
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
Int J Environ Res Public Health. 2015 Oct 21;12(10):13224-39
pubmed: 26506365
Arch Intern Med. 2007 Sep 10;167(16):1720-8
pubmed: 17846390
Glob Health Promot. 2013 Dec;20(4 Suppl):97-103
pubmed: 24722748
PLoS One. 2017 Oct 27;12(10):e0187347
pubmed: 29077762
Lancet Glob Health. 2018 Sep;6(9):e998-e1007
pubmed: 30103999
Health Promot Int. 2009 Mar;24(1):6-15
pubmed: 19171667
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
BMJ Open. 2014 Jul 14;4(7):e005069
pubmed: 25023131
Am J Clin Nutr. 2013 Sep;98(3):637-40
pubmed: 23885045
Antivir Ther. 2012;17(8):1511-9
pubmed: 22910456
Nat Rev Endocrinol. 2020 Mar;16(3):177-189
pubmed: 32020062
J Glob Health. 2017 Jun;7(1):010306
pubmed: 28400949
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1106-1111
pubmed: 31468993
Clin Infect Dis. 2017 Nov 13;65(11):1878-1883
pubmed: 29020319
Int J Obes (Lond). 2017 Oct 03;:
pubmed: 29087388
Pan Afr Med J. 2020 Sep 14;37:49
pubmed: 33209176
Glob Health Promot. 2013 Dec;20(4 Suppl):93-6
pubmed: 24722747
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387
pubmed: 31537368
Glob Health Res Policy. 2019 Nov 29;4:31
pubmed: 31799408